Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - Knowledge to Action Grants -CCSRI

McMaster University

$82,000.00

Evaluating the impact of cancer screening patient decision aids accessed through the McMaster Optimal Aging Portal

EF 2017-18

Résumé
The Canadian Task Force on Preventive Health Care, and other organizations provide specific cancer screening guidelines for those of average risk. For example, women aged 50-69 are recommended to undergo biannual mammography for breast cancer screening, and men of any age with no history of prostate cancer are recommended to not have a Prostate Specific Antigen (PSA) test for prostate cancer screening. While screening tests offer varying degrees of risk and benefit, the outcomes are uncertain for an individual patients. Patient decision aids are “interventions designed to help people make specific and deliberative choices among options by providing information about the options and outcomes that is relevant to a person’s health status". Patient decision aids are easy-to-use, accessible, evidence-based tools that guide individuals through a decision making process which incorporates their needs, preferences and values. A 2017 Cochrane systematic review found beneficial effects on knowledge, decisional conflict, and accuracy of risk perception, particularly for cancer screening decisions. As patient decision aids have been shown to be effective in the research literature, there is a need for effective strategies to encourage their use amongst those who are facing cancer screening decision outside of a research setting. The McMaster Optimal Aging Portal (OAP, http://www.mcmasteroptimalaging.org) is a knowledge translation (KT) platform launched in 2014 to increase public access to trustworthy, evidence-based health information. Userfriendly content provide easy-to-read messages appropriate for all audiences. In 2016, the OAP team received pilot funding to add previously developed, high-quality patient decision aids to the existing resources housed on the OAP. Now we want to know whether access to patient decision aids via the OAP changes what people know and do related to breast and prostate cancer screening. Objective: To evaluate if and how the use of patient decision aids via the OAP, or use of OAP alone, changes decisional conflict, knowledge of screening options, and congruency between a values and preference-based decision to be screened and screening behaviour compared to a control group. Methods: We will use a sequential explanatory mixed-methods design, consisting of a three-arm randomized controlled trial (RCT), followed by a qualitative study for in-depth exploration of the RCT findings and to explore barriers to tinfromation use. This approach will allow for a complete analysis of the outcomes of interest (decisional conflict, knowledge of screening options, and congruency between intention to be screened and screening behaviour), and the KT process. Following baseline data collection, eligible participants will be randomized to one of three groups. Intervention group participants will receive: i) a tailored KT intervention including evidence-based information about breast or prostate cancer screening with the relevant cancer screening decision aid or ii) evidence-based information about breast or prostate cancer screening alone. The attention-control group will receive information on using research evidence unrelated to cancer screening. Quantitative data will be collected to measure decisional conflict, knowledge of cancer screening options, intention to be screened in both groups before and after the intervention. Self-reported screening behaviour will also be collected at 6-month follow up. Qualitative data, in the form of telephone-interviews, will be used to further explore participants’ satisfaction with the information and intervention, understanding of the information and barriers to use. Engagement with the KT strategies will be collected via website and email analytics from all participants.
Programme
Operating Grant - Knowledge to Action Grants -CCSRI
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
378482
Name
Dobbins Maureen J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Cancer Society - National Office (Toronto)
Instname2
Cancer Research
Theme2
Not applicable / Specified
Prcname2
Special Cases
Projecttitle
Evaluating the impact of cancer screening patient decision aids accessed through the McMaster Optimal Aging Portal
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$82,000
Cihrequipment2
$0
Programname2
Operating Grant - Knowledge to Action Grants -CCSRI
Keyworddelim
.
Abstract
The Canadian Task Force on Preventive Health Care, and other organizations provide specific cancer screening guidelines for those of average risk. For example, women aged 50-69 are recommended to undergo biannual mammography for breast cancer screening, and men of any age with no history of prostate cancer are recommended to not have a Prostate Specific Antigen (PSA) test for prostate cancer screening. While screening tests offer varying degrees of risk and benefit, the outcomes are uncertain for an individual patients. Patient decision aids are “interventions designed to help people make specific and deliberative choices among options by providing information about the options and outcomes that is relevant to a person’s health status". Patient decision aids are easy-to-use, accessible, evidence-based tools that guide individuals through a decision making process which incorporates their needs, preferences and values. A 2017 Cochrane systematic review found beneficial effects on knowledge, decisional conflict, and accuracy of risk perception, particularly for cancer screening decisions. As patient decision aids have been shown to be effective in the research literature, there is a need for effective strategies to encourage their use amongst those who are facing cancer screening decision outside of a research setting. The McMaster Optimal Aging Portal (OAP, http://www.mcmasteroptimalaging.org) is a knowledge translation (KT) platform launched in 2014 to increase public access to trustworthy, evidence-based health information. Userfriendly content provide easy-to-read messages appropriate for all audiences. In 2016, the OAP team received pilot funding to add previously developed, high-quality patient decision aids to the existing resources housed on the OAP. Now we want to know whether access to patient decision aids via the OAP changes what people know and do related to breast and prostate cancer screening. Objective: To evaluate if and how the use of patient decision aids via the OAP, or use of OAP alone, changes decisional conflict, knowledge of screening options, and congruency between a values and preference-based decision to be screened and screening behaviour compared to a control group. Methods: We will use a sequential explanatory mixed-methods design, consisting of a three-arm randomized controlled trial (RCT), followed by a qualitative study for in-depth exploration of the RCT findings and to explore barriers to tinfromation use. This approach will allow for a complete analysis of the outcomes of interest (decisional conflict, knowledge of screening options, and congruency between intention to be screened and screening behaviour), and the KT process. Following baseline data collection, eligible participants will be randomized to one of three groups. Intervention group participants will receive: i) a tailored KT intervention including evidence-based information about breast or prostate cancer screening with the relevant cancer screening decision aid or ii) evidence-based information about breast or prostate cancer screening alone. The attention-control group will receive information on using research evidence unrelated to cancer screening. Quantitative data will be collected to measure decisional conflict, knowledge of cancer screening options, intention to be screened in both groups before and after the intervention. Self-reported screening behaviour will also be collected at 6-month follow up. Qualitative data, in the form of telephone-interviews, will be used to further explore participants’ satisfaction with the information and intervention, understanding of the information and barriers to use. Engagement with the KT strategies will be collected via website and email analytics from all participants.
Competitiondate
201706
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dobbins, Maureen J
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $82,000~ $0~